GROUP ONE TRADING LLC - GILEAD SCIENCES INC ownership

GILEAD SCIENCES INC's ticker is and the CUSIP is 375558953. A total of 9 filers reported holding GILEAD SCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of GILEAD SCIENCES INC
ValueSharesWeighting
Q2 2024$6,106,290
+22.6%
89,000
+30.9%
0.02%
+26.3%
Q1 2024$4,981,000
-78.6%
68,000
-76.3%
0.02%
-68.9%
Q4 2023$23,249,870
-16.4%
287,000
-22.7%
0.06%
-34.4%
Q3 2023$27,817,728
+29.2%
371,200
+32.9%
0.09%
+34.8%
Q2 2023$21,525,651
+56.1%
279,300
+68.1%
0.07%
+38.0%
Q1 2023$13,789,614
-40.4%
166,200
-38.3%
0.05%
-7.4%
Q4 2022$23,136,575
+42.1%
269,500
+2.1%
0.05%
+68.8%
Q3 2022$16,280,000
-26.9%
263,900
-26.7%
0.03%
-8.6%
Q2 2022$22,264,000
-52.2%
360,200
-54.0%
0.04%
-23.9%
Q1 2022$46,573,000
-27.0%
783,400
-10.9%
0.05%
-9.8%
Q4 2021$63,817,000
+4.2%
878,900
+0.3%
0.05%
-22.7%
Q3 2021$61,217,000
+11.2%
876,400
+9.7%
0.07%0.0%
Q2 2021$55,033,000
+16.1%
799,200
+8.9%
0.07%
-5.7%
Q1 2021$47,413,000
+5.1%
733,600
-5.3%
0.07%
-10.3%
Q4 2020$45,122,000
+29.2%
774,500
+40.1%
0.08%
-29.1%
Q3 2020$34,931,000
-30.8%
552,800
-15.7%
0.11%
-52.8%
Q2 2020$50,465,000
-22.2%
655,900
-24.4%
0.23%
-55.7%
Q1 2020$64,832,000
+237.3%
867,200
+193.2%
0.53%
+301.5%
Q4 2019$19,221,000
+21.4%
295,800
+18.4%
0.13%
+2.3%
Q3 2019$15,832,000
-6.6%
249,800
-0.4%
0.13%
-16.3%
Q2 2019$16,951,000
+86.3%
250,900
+79.2%
0.15%
+51.5%
Q1 2019$9,101,000
-15.8%
140,000
-19.0%
0.10%
+7.4%
Q4 2018$10,809,000
-35.1%
172,800
-19.9%
0.09%
-28.8%
Q3 2018$16,654,000
+1.0%
215,700
-7.3%
0.13%
-6.4%
Q2 2018$16,492,000
-18.0%
232,800
-12.7%
0.14%
-30.2%
Q1 2018$20,114,000
-42.3%
266,800
-45.2%
0.20%
-17.6%
Q4 2017$34,874,000
+47.9%
486,800
+67.3%
0.24%
+14.5%
Q3 2017$23,577,000
+16.0%
291,000
+1.3%
0.21%
+1.4%
Q2 2017$20,328,000
+13.9%
287,200
+9.3%
0.21%
+1.4%
Q1 2017$17,843,000
-10.6%
262,700
-5.7%
0.21%
+7.2%
Q4 2016$19,951,000
+7.7%
278,600
+19.0%
0.19%
-3.5%
Q3 2016$18,530,000
+66.8%
234,200
+75.8%
0.20%
+53.4%
Q2 2016$11,112,000
-20.5%
133,200
-12.4%
0.13%
-33.5%
Q1 2016$13,972,000
-43.0%
152,100
-37.2%
0.20%
-32.1%
Q4 2015$24,498,000
+39.5%
242,100
+35.4%
0.29%
+19.3%
Q3 2015$17,556,000
-36.1%
178,800
-23.8%
0.24%
-36.7%
Q2 2015$27,455,000
+7.6%
234,500
-9.8%
0.38%
-4.2%
Q1 2015$25,524,000
+285.7%
260,100
+270.5%
0.40%
+301.0%
Q4 2014$6,617,000
+331.6%
70,200
+244.1%
0.10%
+334.8%
Q4 2013$1,533,000
+19.6%
20,4000.0%0.02%
-8.0%
Q3 2013$1,282,000
+18.0%
20,400
-3.8%
0.02%
-7.4%
Q2 2013$1,086,00021,2000.03%
Other shareholders
GILEAD SCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Garda Capital Partners LP 27,000$2,240,1900.11%
GROUP ONE TRADING LLC 166,200$13,789,6140.05%
IMC-Chicago, LLC 390,600$32,408,0820.04%
Maven Securities LTD 12,000$995,6400.02%
Allianz Asset Management GmbH 134,900$11,192,6530.02%
SIMPLEX TRADING, LLC 219,200$18,1870.02%
JPMORGAN CHASE & CO 403,500$33,478,0000.00%
JANE STREET GROUP, LLC 102,600$8,512,7220.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GILEAD SCIENCES INC shareholders